As combinations of drugs from different classes that have synergistic or additive effect and properties to cancel out each others' untoward hemodynamic and metabolic effects become more and more widely used, their use as first-line therapy for the treatment of newly diagnosed hypertensive patients is growing in popularity as well.

More and more combinations are coming out on the market and proving their effectiveness in randomized controlled trials and in large multicenter studies. Compliance of patients is of utmost importance in the control of any chronic disease and multiple coexisting disorders. Fixed combinations can facilitate treatment and improve this issue enormously. The advantages of a fixed combination include use of fewer pills with low individual drug doses that will foster better tolerability, convenience, lower cost and thus ensure better compliance.

We believe that now is the right time for experts in the fields of internal medicine, cardiology, nephrology, family medicine and primary care physicians to meet and discuss the role of fixed combination in the treatment of hypertension and dyslipidemia in today's medicinal world.

CME Credits CME accreditation has been approved by the European Union of Medical Specialists (UEMS).